Matthew S. Zabriskie Department of Radiology and Imaging Sciences University of Utah Biography Publications Institution JoVE Articles Matthew S. Zabriskie has not added a biography. If you are Matthew S. Zabriskie and would like to personalize this page please email our Author Liaison for assistance. Publications MS4A3 Promotes Differentiation in Chronic Myeloid Leukemia by Enhancing Common β-chain Cytokine Receptor Endocytosis Blood. Feb, 2022 | Pubmed ID: 34780648 SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA Blood Cancer Discovery. May, 2021 | Pubmed ID: 34027418 Rabbit Models of Intracranial Atherosclerotic Disease for Pathological Validation of Vessel Wall MRI The Neuroradiology Journal. Jun, 2021 | Pubmed ID: 33325806 Apolipoprotein E Knockout Rabbit Model of Intracranial Atherosclerotic Disease Animal Models and Experimental Medicine. Jun, 2020 | Pubmed ID: 32613180 Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy Against Highly Resistant BCR-ABL1 Mutants Cancer Cell. Oct, 2019 | Pubmed ID: 31543464 A Novel Fusion in Pediatric T-cell Acute Lymphoblastic Leukemia Haematologica. Feb, 2018 | Pubmed ID: 29284681 Mechanisms of Resistance to the BCR-ABL1 Allosteric Inhibitor Asciminib Leukemia. Dec, 2017 | Pubmed ID: 28819281 A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2016 | Pubmed ID: 26673800 Limited Efficacy of BMS-911543 in a Murine Model of Janus Kinase 2 V617F Myeloproliferative Neoplasm Experimental Hematology. Jul, 2015 | Pubmed ID: 25912019 A Coiled-coil Mimetic Intercepts BCR-ABL1 Dimerization in Native and Kinase-mutant Chronic Myeloid Leukemia Leukemia. Aug, 2015 | Pubmed ID: 25721898 Radotinib is an Effective Inhibitor of Native and Kinase Domain-mutant BCR-ABL1 Leukemia. Sep, 2015 | Pubmed ID: 25676420 ShRNA Library Screening Identifies Nucleocytoplasmic Transport As a Mediator of BCR-ABL1 Kinase-independent Resistance Blood. Mar, 2015 | Pubmed ID: 25573989 Combined STAT3 and BCR-ABL1 Inhibition Induces Synthetic Lethality in Therapy-resistant Chronic Myeloid Leukemia Leukemia. Mar, 2015 | Pubmed ID: 25134459 BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-positive Leukemia Cancer Cell. Sep, 2014 | Pubmed ID: 25132497 Threshold Levels of ABL Tyrosine Kinase Inhibitors Retained in Chronic Myeloid Leukemia Cells Determine Their Commitment to Apoptosis Cancer Research. Jun, 2013 | Pubmed ID: 23576564 BCR ABL1 复合突变的酪氨酸激酶抑制剂耐药的 CML: 频率和无性系的关系。 Blood. Jan, 2013 | Pubmed ID: 23223358 Pushing the Limits of Targeted Therapy in Chronic Myeloid Leukaemia Nature Reviews. Cancer. Jul, 2012 | Pubmed ID: 22825216 Nilotinib and MEK Inhibitors Induce Synthetic Lethality Through Paradoxical Activation of RAF in Drug-resistant Chronic Myeloid Leukemia Cancer Cell. Dec, 2011 | Pubmed ID: 22169110 The BCR-ABL35INS Insertion/truncation Mutant is Kinase-inactive and Does Not Contribute to Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Blood. Nov, 2011 | Pubmed ID: 21908430 缺血性脑卒中兔模型中血压的实时监测和调节 Matthew D. Alexander1,2, Guillaume Hoareau3, Matthew S. Zabriskie1, Helen Palatinus3, Nitin Ramanujam Chakravarthula3, Chuanzhuo Wang4, M. Austin Johnson3 1Department of Radiology and Imaging Sciences, University of Utah, 2Department of Neurosurgery, University of Utah, 3Department of Emergency Medicine, University of Utah, 4Department of Radiology, Shengjing Hospital of China Medical University JoVE 64672 Medicina
缺血性脑卒中兔模型中血压的实时监测和调节 Matthew D. Alexander1,2, Guillaume Hoareau3, Matthew S. Zabriskie1, Helen Palatinus3, Nitin Ramanujam Chakravarthula3, Chuanzhuo Wang4, M. Austin Johnson3 1Department of Radiology and Imaging Sciences, University of Utah, 2Department of Neurosurgery, University of Utah, 3Department of Emergency Medicine, University of Utah, 4Department of Radiology, Shengjing Hospital of China Medical University JoVE 64672 Medicina